Nurix Therapeutics Financial Overview
Nurix Therapeutics's market cap is currently $1.88B. The company's EPS TTM is $-1.03; its P/E ratio is -6.24; Nurix Therapeutics is scheduled to report earnings on October 9, 2025, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
